🇺🇸 FDA

Drug profile · INN

cilostazol

CILOSTAZOL

approved
US status
approved
Patents linked
2
News articles
0

Quick answer

cilostazol (CILOSTAZOL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN cilostazol
Brand CILOSTAZOL
Route ORAL
Formulation TABLET
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 9180198

    Slow-release cilostazol tablet having an improved elution rate and minimal side effects

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8426597

    Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cilostazol?

cilostazol (CILOSTAZOL) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for cilostazol?

CILOSTAZOL is a marketed brand name for cilostazol. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cilostazol?

cilostazol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.